Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis.

Lee WP, Wen Y, Varnum B, Hung MC.

Oncogene. 2002 Jan 17;21(3):329-36.

2.

Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily.

Hafizi S, Dahlb├Ąck B.

FEBS J. 2006 Dec;273(23):5231-44. Epub 2006 Oct 25. Review.

3.

Axl-dependent signalling: a clinical update.

Korshunov VA.

Clin Sci (Lond). 2012 Apr;122(8):361-8. doi: 10.1042/CS20110411. Review.

4.

[Advance of study on Mer function].

Fan L, Ruan CG.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Aug;15(4):892-5. Review. Chinese.

PMID:
17708828
5.

AXL kinase as a novel target for cancer therapy.

Wu X, Liu X, Koul S, Lee CY, Zhang Z, Halmos B.

Oncotarget. 2014 Oct 30;5(20):9546-63. Review.

6.

Gene of the month: Axl.

Brown M, Black JR, Sharma R, Stebbing J, Pinato DJ.

J Clin Pathol. 2016 May;69(5):391-7. doi: 10.1136/jclinpath-2016-203629. Epub 2016 Mar 7. Review.

PMID:
26951083
7.

The Gas6/TAM System and Multiple Sclerosis.

Bellan M, Pirisi M, Sainaghi PP.

Int J Mol Sci. 2016 Oct 28;17(11). pii: E1807. Review.

8.

Axl as a mediator of cellular growth and survival.

Axelrod H, Pienta KJ.

Oncotarget. 2014 Oct 15;5(19):8818-52. Review.

9.

AXL-Driven EMT State as a Targetable Conduit in Cancer.

Antony J, Huang RY.

Cancer Res. 2017 Jul 15;77(14):3725-3732. doi: 10.1158/0008-5472.CAN-17-0392. Epub 2017 Jun 30. Review.

PMID:
28667075
10.

New twists in the AXL(e) of tumor progression.

Halmos B, Haura EB.

Sci Signal. 2016 Oct 4;9(448):fs14. Review.

PMID:
27703029
11.

Novel approaches for chemosensitization of breast cancer cells: the E1A story.

Liao Y, Yu D, Hung MC.

Adv Exp Med Biol. 2007;608:144-69. Review.

PMID:
17993239
12.

Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer.

Rothlin CV, Leighton JA, Ghosh S.

Inflamm Bowel Dis. 2014 Aug;20(8):1472-80. doi: 10.1097/MIB.0000000000000050. Review.

13.

Molecular insights of Gas6/TAM in cancer development and therapy.

Wu G, Ma Z, Hu W, Wang D, Gong B, Fan C, Jiang S, Li T, Gao J, Yang Y.

Cell Death Dis. 2017 Mar 23;8(3):e2700. doi: 10.1038/cddis.2017.113. Review.

14.

TAM receptors in apoptotic cell clearance, autoimmunity, and cancer.

Nguyen KQ, Tsou WI, Kotenko S, Birge RB.

Autoimmunity. 2013 Aug;46(5):294-7. doi: 10.3109/08916934.2013.794515. Epub 2013 May 10. Review.

PMID:
23662598
15.

AXL receptor tyrosine kinase as a therapeutic target in NSCLC.

Okimoto RA, Bivona TG.

Lung Cancer (Auckl). 2015 Apr 30;6:27-34. doi: 10.2147/LCTT.S60438. eCollection 2015. Review.

Supplemental Content

Support Center